Hofseth Biocare ASA: Correction of minutes from Extraordinary General Meeting held 20 September 2016
September 30 2016 - 1:30PM
Reference is made to the announcement regarding
the completion of the Extraordinary General Meeting (EGM) in
Hofseth BioCare ASA ("HBC" or the "Company", ticker "HBC") held 20
September 2016.
Please note that the Company subsequent to the
general meeting have become aware that the number of Allocation
Rights each Eligible Shareholder is entitled to is misquoted in the
minutes from the general meeting. The correct number of Allocation
Rights each Eligible shareholder is entitled to is 0.16772555156,
which is equivalent to what now is stated in the Prospectus.
Furthermore, it is stated in the minutes that the subscription
period in the subsequent offering ends 17 October 2016 at 12:00
hours (CET), while the correct time according to applicable rules
is 16:30 hours (CET) so that the correct subscription and trading
period for the Allocations Rights is from 3 October 2016 at 09:00
hours (CET) to 17 October 2016 at 16:30 hours (CET).
Both these misquotations have been amended in the
attached updated minutes from the EGM.
For further information, please contact:
Jon Olav Ødegård, CFO of Hofseth BioCare ASA
Phone: +47 936 32 966
E-mail: joo@hofsethbiocare.no
About Hofseth BioCare ASA:
HBC is a Norwegian biotech company that offers
high-value ingredients and finished products for humans and pets.
The company is founded on the core values of sustainability,
traceability and optimal utilization of natural resources. Through
an innovative hydrolysis technology, HBC is able to preserve the
quality of salmon oil, proteins and calcium, prepared of fresh
salmon off-cuts. HBC's objective is to contribute to the efficient
use of marine resources and deliver quality products for
ingredients and finished consumer products in the nutrition
market.
Hofseth BioCare's headquarters are located in
Ålesund, Norway with branches in Oslo, Chicago, Mumbai and Tokyo.
HBC is listed on Oslo Stock Exchange Axess list with ticker "HBC".
More information about Hofseth BioCare at www.hofsethbiocare.com
and www.facebook.com/hofsethbiocare
This information is subject
to the disclosure requirements pursuant to section 5-12 of the
Norwegian Securities Trading Act.
Minutes EGM HBC 200916
This
announcement is distributed by Nasdaq Corporate Solutions on behalf
of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely
responsible for the content, accuracy and originality of the
information contained therein.
Source: Hofseth Biocare ASA via Globenewswire